MyFinsight
Home
Blog
About
Back
Income Statement
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)
source: myfinsight.com
Gain on change in fair
value of contingent...
-$49,200,000
(-39.38%↓ Y/Y)
Interest income
$1,103,000
(-36.90%↓ Y/Y)
Other income
(expense), net
$126,000
(2620.00%↑ Y/Y)
Total other income,
net
$44,924,000
Loss on change in fair
value of embedded...
$4,535,000
Interest expense
$852,000
(loss) gain on change in
fair value of warrant...
$118,000
(118.04%↑ Y/Y)
Net income (loss)
$15,769,000
(-0.74%↓ Y/Y)
Operating loss
-$29,155,000
(-33.67%↓ Y/Y)
Net income (loss)
allocable to shares of...
$13,720,000
Less undistributed
earnings allocable to...
$2,049,000
Total operating
expenses
$29,155,000
(31.87%↑ Y/Y)
Research and development
$20,431,000
(37.41%↑ Y/Y)
General and
administrative
$8,724,000
(20.50%↑ Y/Y)
Back